HomeBUSINESS
BUSINESS

Parkinson’s Med Nouriast Fails in PIII Study in US, Europe: Kyowa Kirin
(Dec.14.2016)

Kyowa Hakko Kirin said on December 13 that its Parkinson’s disease treatment istradefylline, which is sold under the Nouriast brand in Japan, failed to meet the primary endpoint in a PIII study conducted in North America and Europe ...
(LOG IN FOR FULL STORY)

News Calendar